Arko (ARKOW) has had the lowest return since October 10, 2024 by a US stock with a market cap of $1B+, returning -98.1%.
| ASSET | % RETURN |
|---|---|
Arko (ARKOW) | -98.1% |
Advantage Solutions (ADVWW) | -86.15% |
Sarepta Therapeutics (SRPT) | -80.68% |
Office Properties Income Trust (OPINL) | -78.25% |
GCM Grosvenor (GCMGW) | -77.78% |
Globant (GLOB) | -71.64% |
Celanese (CE) | -68.11% |
PACS (PACS) | -65.99% |
Biohaven Pharmaceutical (BHVN) | -65.95% |
Enphase Energy (ENPH) | -64.47% |
Freshpet (FRPT) | -64.12% |
Vaxcyte (PCVX) | -62.09% |
Braskem SA Class A (BAK) | -61.83% |
Tandem Diabetes Care (TNDM) | -61.75% |
Inspire Medical Systems (INSP) | -60.94% |
Huntsman (HUN) | -60.05% |
LGI Homes (LGIH) | -57.25% |
Maravai Lifesciences Holdings (MRVI) | -56.75% |
Alight (ALIT) | -55.72% |
Dow (DOW) | -55.53% |
Acadia Healthcare (ACHC) | -54.09% |
Neogen (NEOG) | -54.03% |
Lotus Technology Inc American Depositary Shares (LOT) | -53.79% |
Dyne Therapeutics (DYN) | -53.25% |
Moderna (MRNA) | -52.87% |
